Sexually Transmitted Infections Treatment Guidelines, 2021
Open accessThe DOI matches its Crossref record; 1,459 of the 1,505 references it cites were found in a registry or an index; 371 of the 802 sources its claims cite were checked for support.
Abstract
These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3) alternative treatment options for bacterial vaginosis; 4) management of Mycoplasma genitalium; 5) human papillomavirus vaccine recommendations and counseling messages; 6) expanded risk factors for syphilis testing among pregnant women; 7) one-time testing for hepatitis C infection; 8) evaluation of men who have sex with men after sexual assault; and 9) two-step testing for serologic diagnosis of genital herpes simplex virus. Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs.
Overview
CoChat Summary
TL;DR
These CDC guidelines update the 2015 STI treatment recommendations after expert consultation and systematic literature review, covering prevention, diagnosis, treatment, and special populations. They include updated guidance for gonorrhea, chlamydia, trichomoniasis, pelvic inflammatory disease, bacterial vaginosis, *Mycoplasma genitalium*, HPV vaccination, syphilis screening in pregnancy, hepatitis C testing, sexual assault evaluation, and HSV serology.
Key findings
- Congenital syphilis in the United States increased from 8.4 to 48.5 cases per 100,000 births during 2012–2019, a 477.4% increase.
- Three randomized controlled trials in sub-Saharan Africa found male circumcision reduced HIV acquisition among men by 50%–60%; HPTN 052 found ART for the infected partner decreased HIV transmission to uninfected heterosexual partners by 96%.
- Doxycycline postexposure prophylaxis after unprotected anal sex among MSM and transgender women reduced incident chlamydia and syphilis by 70% and 73%, respectively, but had no effect on gonorrhea.
- Expedited partner therapy trials showed reductions in chlamydia prevalence at follow-up of approximately 20% and gonorrhea of approximately 50%.
Methods
- CDC staff worked with subject matter experts to identify key questions and conduct systematic MEDLINE-based literature reviews for each section of the 2015 guidelines, focused on microbiologic eradication, symptom alleviation, prevention of sequelae, and prevention of transmission.
- Experts presented literature assessments at an in-person meeting in Atlanta, Georgia, June 11–14, 2019; evidence was rated high, medium, or low using USPSTF-style ratings, and draft recommendations underwent peer review and a public webinar before finalization.
- Recommendations for HIV, hepatitis C, cervical cancer screening, STI screening in pregnancy, HPV testing, and HAV/HBV vaccination were developed after reviewing existing published recommendations.
Limitations
- The paper states these guidelines are “a source of clinical guidance rather than prescriptive standards” and that providers should consider each person’s clinical circumstances and local disease prevalence.
- The paper states several evidence gaps, including limited data on doxycycline STI prophylaxis, no long-term data on STI postexposure prophylaxis effects on antimicrobial resistance and the microbiome, and insufficient data to recommend routine anal cancer screening with anal cytology.
- Evident from the text: many recommendations, especially for syphilis treatment, rely on decades of clinical experience and observational data rather than randomized controlled trials; the document is a broad guideline rather than a single primary study with a defined sample or comparator.
Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
221 Valid · 41 Not valid · 158 Not checked · 82 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Adherence can be low (48), and prevention of HIV infection, especially among women, has not been demonstrated (47,49).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Clinical Prevention Guidance > Primary Prevention Methods
What the sources say
- Disputedcites [47] Abdool Karim Q, Abdool Karim SS, Frohlich JA,; CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329: 1168– 74. Erratum in: Science 2011;333:524. 10.1126/science.1193748 20643915 PMC3001187 sourceExperimental — accuracy not yet measured
The Results (‘HIV incidence and effectiveness’; page unavailable) report 5.6 HIV infections per 100 women-years with tenofovir gel versus 9.1 with placebo (p=0.017) in a trial of women. The Discussion states that the gel reduced HIV infection by an estimated 39%. Although the authors call for corroboration, their findings directly contradict the claim that prevention had not been demonstrated. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [49] Delany-Moretlwe S, Lombard C, Baron D, Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2018; 18: 1241– 50. 10.1016/S1473-3099(18)30428-6 30507409 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In addition, nontreponemal test titers might decrease more slowly for persons previously treated for syphilis (594,595).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Could not verifycites [594] Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007; 83: 97– 101. 10.1136/sti.2006.021402 16943224 PMC2598600 sourceExperimental — accuracy not yet measured
The Results (page unavailable) mention a history of syphilis infection, but do not compare titre declines by prior treatment history. The paper compares response times by HIV status and syphilis stage; searches for prior treatment and serological response found no passage addressing whether previously treated patients’ titres decline more slowly. (LLM, conf=0.76)
- Disputedcites [595] Seña AC, Wolff M, Martin DH, Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis. Clin Infect Dis 2011; 53: 1092– 9. 10.1093/cid/cir671 21998287 PMC3205200 sourceExperimental — accuracy not yet measured
In Characteristics Associated With Serological Cure (page unavailable), the paper reports that a history of syphilis was not significantly associated with serological cure; the Discussion likewise says it found no association between history of syphilis and serological response. It mentions a prior study finding less seroreversion after repeat infection, but that is not a finding that titers decrease more slowly in previously treated persons. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that use of additional doses of benzathine penicillin G, amoxicillin, or other antibiotics do not enhance efficacy of this recommended regimen when used to treat primary and secondary syphilis, regardless of HIV status (591–593).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Not checked — no full text of the sourcecites [591] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) explicitly says that, among HIV-infected patients with early syphilis, one dose of benzathine penicillin G was inferior to three weekly doses for serological response at 12 months—the opposite of the claim about additional doses. The study excluded patients who received other antibiotics, so it does not establish whether adding amoxicillin or other antibiotics helps; it also does not establish the claim regardless of HIV status. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Factors Associated With Treatment Response section reports similar responses with one versus multiple BPG doses in HIV-infected people with early syphilis. The study does not establish that adding amoxicillin or other antibiotics to the recommended regimen offers no benefit: its “other” regimens were grouped together and could be alternatives rather than additions. Nor do its findings establish the result regardless of HIV status; the Discussion also notes limited power for people with advanced immunosuppression. Page numbers were not available in our copy. (LLM, conf=0.89)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in early latent syphilis do not enhance efficacy, regardless of HIV status (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Latent Syphilis
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were associated with a higher serological response than one dose in patients with HIV and early syphilis; the Discussion explicitly calls the one-dose regimen inferior at 12 months. This contradicts the claim that additional doses do not enhance efficacy. The study did not test additional amoxicillin or other antibiotics, or patients without HIV. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results report similar treatment responses with one versus multiple BPG doses in HIV-infected people with early syphilis. However, the Data Analysis and Definitions section says syphilis stage was not consistently captured, and the study did not establish the claim specifically for early latent syphilis, amoxicillin or other added antibiotics, or people without HIV. The Discussion further limits its conclusion to patients with preserved CD4 counts and low viral loads. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in primary and secondary syphilis among persons with HIV infection do not result in enhanced efficacy (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Syphilis Among Persons with HIV Infection
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were independently associated with a higher serological response than one dose in HIV-infected patients with early syphilis. The Discussion says the subgroup results generally favored three doses, except among patients presenting with primary syphilis; the study did not test additional amoxicillin or other antibiotics. These findings contradict the cited sentence’s blanket claim of no enhanced efficacy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results (Factors Associated With Treatment Response; page not provided) found similar serologic responses with one versus multiple BPG doses in HIV-infected people with early syphilis. It also found no improved response for a pooled “other” regimen group, but the Data Analysis and Definitions section says that group combined penicillin derivatives used alone or with BPG and non-penicillin antibiotics. The paper therefore does not establish the claim specifically for additional amoxicillin or each other antibiotic. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
264 more claims · 126 with their cited sources checked
Create a free account to see all 502 claims and to verify the 10 references still open.
- Probably not a substantial claim. 72
- It may state two separate claims as one. 188
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and a reduction of half the risk of perinatal death (RR, 0.50; 95% CI: 0.33-0.84) (5) as long as treatment for GS been administered 30 days before delivery 5.”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The strategy of early diagnosis with rapid tests and immediate treatment (on the same day) with at least one dose of benzathine penicillin leads to a reduction of about 98% in the incidence of CS (relative risk (RR), 0.02; 95% confidence interval (CI: 0.00-0.18)”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer that is fourfold§ (or greater) higher than the mother’s titer at delivery (e.g., maternal titer = 1:2, neonatal titer ≥1:8 or maternal titer = 1:8, neonatal titer ≥1:32)¶;”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer equal to or less than fourfold of the maternal titer at delivery (e.g., maternal titer = 1:8, neonatal titer ≤1:16)”
Citations
Cites
Items 801–1,000 of 1,461
Hepatitis B vaccination coverage among high-risk adults 18–49 years, U.S., 2009.
Lu, P.-J., Byrd, K. K., Murphy, T. V., & Weinbaum, C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.030 · Cited by 64
Chosidow, O., Drouault, Y., Leconte-Veyriac, F., Aymard, M., Ortonne, J. ‐., Pouget, F., Revuz, J. E., Decazes, J. M., & Malkin, J. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04139.x · Cited by 64
Schwebke, J. R., Gaydos, C. A., Davis, T., Marrazzo, J. M., Furgerson, D., Taylor, S. N., Smith, B., Bachmann, L. H., Ackerman, R. T., Spurrell, T., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01091-17 · Cited by 64
Self-citationMorrow, R. A., & Friedrich, D. A. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01370.x · Cited by 64
Primary sigmoid vaginoplasty in transwomen: technique and outcomes.
Salgado, C. J., Nugent, A., Kuhn, J., Janette, M., & Bahna, H. (2018) · BioMed Research International · doi:10.1155/2018/4907208 · Cited by 64
Hammer, G. P., Kellogg, T. A., McFarland, W. C., Wong, E., Louie, B., Williams, I., Dilley, J., Page-Shafer, K., & Klausner, J. D. (2003) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000091152.31366.e6 · Cited by 64
Accuracy of Five Different Diagnostic Techniques inMild‐to‐Moderate Pelvic Inflammatory Disease
Gaitán, H., Ángel, E., Diaz, R., et al. (2002) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/s1064744902000194 · Cited by 63
Reactivation of Herpes Simplex Virus Type 2 After Initiation of Antiretroviral Therapy
Tobian, A. A. R., Grabowski, M. K., Serwadda, D., Newell, K., Ssebbowa, P., Franco, V., Nalugoda, F. K., Wawer, M. J., Gray, R. H., Quinn, T. C., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit252 · Cited by 63
Roth, A. M., Williams, J. A., Ly, R., Curd, K., Brooks, D., Arno, J. N., & Pol, B. J. V. D. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318203e3ce · Cited by 63
Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study
Judlin, P., Liao, Q., Liu, Z., Reimnitz, P., Hampel, B., & Arvis, P. (2010) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02687.x · Cited by 62
Miguel, R. D. V., Chivukula, M., Krishnamurti, U., Amortegui, A. J., Kant, J. A., Sweet, R. L., Wiesenfeld, H. C., Phillips, J. M., & Cherpes, T. L. (2011) · Pathology - Research and Practice · doi:10.1016/j.prp.2011.08.007 · Cited by 62
Flagg, E. W., & Torrone, E. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.304119 · Cited by 62
Maternal and congenital syphilis in Shanghai, China, 2002 to 2006
Zhu, L., Qin, M., Du, L., Xie, R.-H., Wong, T., & Wen, S. W. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.09.009 · Cited by 62
Abbai, N. S., Reddy, T., & Ramjee, G. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462415616038 · Cited by 62
Burnett, A., Anderson, C. P., & Zwank, M. D. (2011) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2011.07.014 · Cited by 62
Sexually acquired metronidazole-resistant trichomoniasis in a lesbian couple.
Kellock, D., & O'Mahony, C. P. (1996) · Sexually Transmitted Infections · doi:10.1136/sti.72.1.60 · Cited by 61
Kouyoumdjian, F. G., Leto, D., John, S., Henein, H., & Bondy, S. (2012) · International Journal of STD & AIDS · doi:10.1258/ijsa.2011.011194 · Cited by 61
Linas, B. P., Wong, A. Y., Schackman, B. R., Kim, A. Y., & Freedberg, K. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis382 · Cited by 61
Celum, C., Morrow, R. A., Donnell, D., Hong, T., Hendrix, C. W., Thomas, K. K., Fife, K. H., Nakku-Joloba, E., Mujugira, A., Baeten, J. M., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2471 · Cited by 61
Pitasi, M. A., Kerani, R. P., Kohn, R., Murphy, R. D., Pathela, P., Schumacher, C. M., Tabidze, I., & Llata, E. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000917 · Cited by 61
Bérard, A., Sheehy, O., Zhao, J.-P., Gorgui, J., Bernatsky, S., de Moura, C. S., & Abrahamowicz, M. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.180963 · Cited by 61
Van Der Pol, B., Williams, J. A., Taylor, S. N., Cammarata, C. L., Rivers, C. A., Body, B. A., Nye, M., Fuller, D., Schwebke, J. R., Barnes, M., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02966-13 · Cited by 61
Pol, B. J. V. D., Williams, J. A., Fuller, D., Taylor, S. N., & Hook, E. W. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01766-16 · Cited by 61
Vandepitte, J., Weiss, H. A., Bukenya, J. N., et al. (2014) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051467 · Cited by 61
Aghaizu, A., Reid, F., Kerry, S., et al. (2014) · Sexually Transmitted Infections · doi:10.1136/sextrans-2014-051607 · Cited by 61
Lin, J. S., Eder, M. L., & Bean, S. (2018) · JAMA · doi:10.1001/jama.2018.7769 · Cited by 61
Mycoplasma genitalium in chronic non-gonococcal urethritis
TAYLOR‐ROBINSON, D., Gilroy, C. B., Thomas, B. J., & Hay, P. (2003) · International Journal of STD & AIDS · doi:10.1258/095646204322637209 · Cited by 60
Gift, T. L., Gaydos, C. A., Kent, C. K., Marrazzo, J. M., Rietmeijer, C. A., Schillinger, J. A., & Dunne, E. F. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31818b64ac · Cited by 60
Risk factors for HCV acquisition among HIV-positive MSM in Belgium.
Apers, L., Vanden Berghe, W., De Wit, S., Kabeya, K., Callens, S., Buyze, J., Kenyon, C., Florence, E., & Buvé, A. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000528 · Cited by 60
Efficacy of commercial condoms in the prevention of hepatitis B virus infection
Minuk, G. Y., Bohme, C. E., Bowen, T., Hoar, D., Cassol, S. A., Gill, M. J., & Clarke, H. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90431-8 · Cited by 60
Muzny, C. A., Blackburn, R. J., Sinsky, R. J., Austin, E. L., & Schwebke, J. R. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu446 · Cited by 60
Self-citationEdwards, R. K., Ferguson, R. J., Reyes, L., Brown, M. B., Theriaque, D. W., & Duff, P. (2006) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/00207170600712071 · Cited by 60
Cranston, R. D., Lama, J. R., Richardson, B. A., Carballo-Diéguez, A., Kunjara Na Ayudhya, R. P., Liu, K., Patterson, K. B., Leu, C.-S., Galaska, B., Jacobson, C. E., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw832 · Cited by 60
Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection
Renault, C. A., Israelski, D. M., Levy, V., Fujikawa, B. K., Kellogg, T. A., & Klausner, J. D. (2011) · Sexual Health · doi:10.1071/sh10030 · Cited by 60
Deza, G., Martin-Ezquerra, G., Gómez, J., Villar-García, J., Supervia, A., & Pujol, R. M. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052135 · Cited by 59
Marcus, U., Zucs, P., Bremer, V, Hamouda, O., Prager, R., Tschaepe, H., Futh, U., & Kramer, M. (2004) · International Journal of STD & AIDS · doi:10.1258/0956462041558221 · Cited by 59
Effectiveness of Two Tinidazole Regimens in Treatment of Bacterial Vaginosis
Livengood, C. H., Ferris, D. G., Wiesenfeld, H. C., Hillier, S. L., Soper, D. E., Nyirjesy, P., Marrazzo, J. M., Chatwani, A. J., Fine, P., Sobel, J. D., et al. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000275282.60506.3d · Cited by 59
Shah, S. S., Ebberson, J., Kestenbaum, L. A., Hodinka, R. L., & Zorc, J. J. (2011) · Journal of Hospital Medicine · doi:10.1002/jhm.711 · Cited by 59
Brinkley‐Rubinstein, L., Peterson, M., Arnold, T. L., Nunn, A. S., Beckwith, C. G., Castonguay, B. J. U., Junious, E., Lewis, C., & Chan, P. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205593 · Cited by 59
Self-citationLeis, J. A., Palmay, L., Ho, G., Raybardhan, S., Gill, S., Kan, T., Campbell, J., Kiss, A., McCready, J. B., Das, P., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix512 · Cited by 59
Cina, M., Baumann, L., Egli-Gany, D., et al. (2019) · Sexually Transmitted Infections · doi:10.1136/sextrans-2018-053823 · Cited by 59
Pharmacokinetics of a single 1g dose of azithromycin in rectal tissue in men
Kong, F. Y. S., Rupasinghe, T., Simpson, J. A., Vodstrcil, L. A., Fairley, C. K., McConville, M. J., & Hocking, J. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174372 · Cited by 59
Machalek, D. A., Grulich, A. E., Jin, F., Templeton, D. J., & Poynten, I. M. (2012) · Sexual Health · doi:10.1071/sh12043 · Cited by 59
A systematic review of epidemiologic studies assessing condom use and risk of syphilis.
Koss, C. A., Dunne, E. F., & Warner, L. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181a396eb · Cited by 59
Bukusi, E. A., Cohen, C. R., Stevens, C. E., Sinei, S. K., Reilly, M., Grieco, V., Eschenbach, D. A., Holmes, K. K., Bwayo, J., Ndinya‐Achola, J. O., et al. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70378-9 · Cited by 58
Rosenthal, S. L., Zimet, G. D., Leichliter, J. S., Stanberry, L. R., Fife, K. H., Tu, W., & Bernstein, D. I. (2006) · Sexually Transmitted Infections · doi:10.1136/sti.2005.016311 · Cited by 58
Anogenital human papillomavirus in sexually abused and nonabused children: a multicenter study.
Unger, E. R., Fajman, N. N., Maloney, E. M., Onyekwuluje, J., Swan, D. C., Howard, L., Beck-Sague, C. M., Sawyer, M. K., Girardet, R. G., Sautter, R. L., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-2247 · Cited by 58
Recent epidemiology of sexually transmissible enteric infections in men who have sex with men
Mitchell, H. D., & Hughes, G. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000423 · Cited by 58
Bowen, A., Grass, J., Bicknese, A., Campbell, D., Hurd, J., & Kirkcaldy, R. D. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2209.160624 · Cited by 58
Persistent, UndetectedTrichomonas vaginalisInfections?
Peterman, T. A., Tian, L. H., Metcalf, C. A., Malotte, C. K., Paul, S. M., Douglas, J. M., & RESPECT‐2 Study Group (2008) · Clinical Infectious Diseases · doi:10.1086/595706 · Cited by 58
Kacmar, J., Cheh, E., Montagno, A., & Peipert, J. F. (2001) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/s1064744901000321 · Cited by 58
Freeman, A. H., Bernstein, K. T., Kohn, R. P., Philip, S., Rauch, L. M., & Klausner, J. D. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318227713e · Cited by 58
Schwebke, J. R., & Desmond, R. A. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181dd1691 · Cited by 57
Prevalence and Treatment Outcome of Cervicitis of Unknown Etiology
Taylor, S. N., Lensing, S., Schwebke, J. R., Lillis, R., Mena, L. A., Nelson, A. L., Rinaldi, A., Saylor, L., McNeil, L., & Lee, J. Y. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31828bfcb1 · Cited by 57
Goodreau, S. M., & Golden, M. R. (2007) · Sexually Transmitted Infections · doi:10.1136/sti.2007.025627 · Cited by 57
Vazquez, J. A., Peng, G., Sobel, J. D., Steele‐Moore, L., Schuman, P., Holloway, W., Neaton, J. D., & (CPCRA), T. T. B. C. P. F. C. R. O. A. (2001) · Clinical Infectious Diseases · doi:10.1086/322641 · Cited by 57
Stokes-Lampard, H. J., Wilson, S., Waddell, C., Ryan, A. V., Holder, R. L., & Kehoe, S. T. (2006) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01099.x · Cited by 57
(2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31826f36de · Cited by 57
Mujugira, A., Magaret, A., Celum, C., Baeten, J. M., Lingappa, J. R., Morrow, R. A., Fife, K. H., Delany‐Moretlwe, S., de Bruyn, G., Bukusi, E. A., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit333 · Cited by 56
Lewis, D. A. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.892414 · Cited by 56
Podophyllum: Suspected Teratogenicity from Topical Application
Karol, M. D., Conner, C. S., Watanabe, A. S., et al. (1980) · Clinical Toxicology · doi:10.3109/15563658008989950 · Cited by 56
Canvin, M., Sinka, K., Hughes, G., & Mesher, D. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052626 · Cited by 56
ROMANOWSKI, B., MARINA, R. B., & ROBERTS, J. N. (2003) · Sexually Transmitted Diseases · doi:10.1097/00007435-200303000-00010 · Cited by 56
Shigella Enteritis Venereally Transmitted
(1974) · New England Journal of Medicine · doi:10.1056/nejm197411282912223 · Cited by 56
Microbial invasion of the amniotic cavity in midtrimester pregnancies using molecular microbiology
Rowlands, S., Danielewski, J., Tabrizi, S. N., Walker, S. P., & Garland, S. M. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.02.051 · Cited by 55
Shahid, Z., & Sobel, J. D. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.03.021 · Cited by 55
Classification of non-gonococcal urethritis: a review
Sarıer, M., & Kukul, E. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02140-2 · Cited by 55
Marcus, J. L., Kohn, R. P., Barry, P. M., Philip, S., & Bernstein, K. T. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182029008 · Cited by 55
High and persistent HIV seroincidence in men who have sex with men across 47 U.S. cities.
Ackers, M.-L., Greenberg, A. E., Lin, C. Y., Bartholow, B. N., Goodman, A. H., Longhi, M., & Gurwith, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034972 · Cited by 55
Anderson, T. A., Schick, V, Herbenick, D., Dodge, B., & Fortenberry, J. D. (2014) · Sexually Transmitted Infections · doi:10.1136/sextrans-2014-051558 · Cited by 55
Hepatitis B Vaccination Coverage Among Adults—United States, 2004
(2006) · JAMA · doi:10.1001/jama.296.1.33 · Cited by 55
Sawaya, G. F., Sanstead, E. C., Alarid‐Escudero, F., Smith‐McCune, K., Gregorich, S. E., Silverberg, M. J., Leyden, W. A., Huchko, M. J., Kuppermann, M., & Kulasingam, S. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0299 · Cited by 55
Flagg, E. W., Meites, E., Phillips, C., Papp, J. R., & Torrone, E. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001013 · Cited by 55
Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis
Zikic, A., Schünemann, H. J., Wi, T., Lincetto, O., Broutet, N. J. N., & Santesso, N. A. (2018) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piy060 · Cited by 55
Ota, K. V., Fisman, D. N., Tamari, I. E., Smieja, M., Ng, L., Jones, K. E., DiPrima, A., & Richardson, S. E. (2009) · Clinical Infectious Diseases · doi:10.1086/597586 · Cited by 54
Signs or symptoms of acute HIV infection in a cohort undergoing community-based screening.
Hoenigl, M., Green, N., Camacho, M., Gianella, S., Mehta, S. R., Smith, D. M., & Little, S. J. (2016) · Emerging infectious diseases · doi:10.3201/eid2203.151607 · Cited by 54
Ganesan, A., Mesner, O., Okulicz, J. F., O'Bryan, T., Deiss, R. G., Lalani, T., Whitman, T. J., Weintrob, A. C., Macalino, G., & Agan, B. K. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu888 · Cited by 54
Wilson, T. E., Hogben, M., Malka, E. S., Liddon, N., McCormack, W. M., Rubin, S. R., & Augenbraun, M. A. (2009) · American Journal of Public Health · doi:10.2105/ajph.2007.112128 · Cited by 54
Möller, B., TAYLOR‐ROBINSON, D., Furr, P. M., & Freundt, E. A. (1985) · PubMed · Cited by 54
Schwebke, J. R., Lensing, S. Y., Lee, J., Muzny, C. A., Pontius, A., Woznicki, N., Aguin, T., & Sobel, J. D. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1903 · Cited by 54
Self-citationEffect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples
Magaret, A., Mujugira, A., Hughes, J. P., Lingappa, J., Bukusi, E. A., DeBruyn, G., Delany-Moretlwe, S., Fife, K. H., Gray, G. E., Kapiga, S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ908 · Cited by 54
Park, M. A., Koch, C. A., Klemawesch, P., Joshi, A., & Li, J. T. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000314367 · Cited by 54
Use of barrier protection for sexual activity among women who have sex with women
Rowen, T. S., Breyer, B. N., Lin, T., Li, C., Robertson, P. A., & Shindel, A. W. (2012) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2012.08.011 · Cited by 54
An Observational Cohort Study of Chlamydia trachomatis Treatment in Pregnancy
Rahangdale, L., Guerry, S., Bauer, H. M., Packel, L., Rhew, M., Baxter, R., Chow, J., & Bolan, G. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000187226.32145.ea · Cited by 53
Self-citationGitman, M., Ferguson, D. J. P., & Landry, M. L. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01413-13 · Cited by 53
Chesson, H. W., Bernstein, K. T., Gift, T. L., Marcus, J. L., Pipkin, S., & Kent, C. K. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318284e544 · Cited by 53
Dize, L., Barnes, P., Barnes, M., Hsieh, Y., Marsiglia, V. C., Duncan, D., Hardick, J. P., & Gaydos, C. A. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.07.018 · Cited by 53
The clinical spectrum of Trichomonas vaginalis infection and challenges to management
Muzny, C. A., & Schwebke, J. R. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050893 · Cited by 53
Self-citationPossible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod
Mashiah, J., & Brenner, S. (2007) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2007.02520.x · Cited by 53
Schick, V., Rosenberger, J. G., Herbenick, D., & Reece, M. (2012) · Sexually Transmitted Infections · doi:10.1136/sextrans-2011-050404 · Cited by 53
Health and health risks among sexual minority women: an examination of 3 subgroups.
Przedworski, J. M., McAlpine, D. D., Karaca-Mandic, P., & VanKim, N. A. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301733 · Cited by 52
Treatment of Gonococcal Conjunctivitis With Single-Dose Intramuscular Ceftriaxone
Haimovici, R., & Roussel, T. J. (1989) · American Journal of Ophthalmology · doi:10.1016/0002-9394(89)90495-9 · Cited by 52
Mitchell, C. M., Manhart, L. E., Thomas, K., Fiedler, T. L., Fredricks, D. N., & Marrazzo, J. M. (2012) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2012/706540 · Cited by 52
Schwebke, J. R., Morgan, F. G., Koltun, W. D., & Nyirjesy, P. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.08.017 · Cited by 52
US Preventive Services Task Force, Bibbins-Domingo, K. B., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., García, F., Kemper, A. R., Krist, A. H., Kurth, A., et al. (2016) · JAMA · doi:10.1001/jama.2016.16776 · Cited by 52
Ramjee, G., van der Straten, A., Chipato, T., de Bruyn, G., Blanchard, K., Shiboski, S., Cheng, H., Montgomery, E., Padian, N., & for the MIRA team (2008) · PLoS ONE · doi:10.1371/journal.pone.0003488 · Cited by 52
van der Linden, N., Gool, K. V., Gardner, K., Dickinson, H., Agostino, J., Regan, D. G., Dowden, M., & Viney, R. C. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007182 · Cited by 52
Kjær, H. O. (2000) · Sexually Transmitted Infections · doi:10.1136/sti.76.3.169 · Cited by 52
Ugwumadu, A. H. N., Reid, F., Hay, P., & Manyonda, I. (2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000130068.21566.4e · Cited by 52
Scholes, D., Satterwhite, C. L., Yu, O., Fine, D., Weinstock, H., & Berman, S. M. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31823e3009 · Cited by 51
Cao, Y., Su, X., Wang, Q., Xue, H., Zhu, X., Zhang, C., Jiang, J., Qi, S., Gong, X., Zhu, X., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix611 · Cited by 51
On behalf of the PROUD Study Group, Dolling, D. I., Desai, M., McOwan, A., Gilson, R., Clarke, A., Fisher, M., Schembri, G., Sullivan, A. K., Mackie, N., et al. (2016) · Trials · doi:10.1186/s13063-016-1286-4 · Cited by 51
Berenger, B. M., Demczuk, W., Gratrix, J., Pabbaraju, K., Smyczek, P., & Martín, I. (2019) · Emerging infectious diseases · doi:10.3201/eid2509.190407 · Cited by 51
US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., et al. (2019) · JAMA · doi:10.1001/jama.2018.21367 · Cited by 51
Stekler, J., Bachmann, L., Brotman, R. M., Erbelding, E. J., Lloyd, L. V., Rietmeijer, C. A., Handsfield, H. H., Holmes, K. K., & Golden, M. R. (2005) · Clinical Infectious Diseases · doi:10.1086/428043 · Cited by 51
Matthias, J. M., Rahman, M. M., Newman, D. R., & Peterman, T. A. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000638 · Cited by 51
Yang, C.-J., Lee, N.-Y., Chen, T.-C., Lin, Y.-H., Liang, S.-H., Lu, P.-L., Huang, W.-C., Tang, H.-J., Lee, C.-H., Lin, H.-H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109667 · Cited by 51
A Practical Approach to the Diagnosis of Pelvic Inflammatory Disease
Jaiyeoba, O., & Soper, D. E. (2011) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2011/753037 · Cited by 51
Lewis, D. A., & Mitjà, J. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000226 · Cited by 50
Tepper, N. K., Steenland, M. W., Gaffield, M. E., Marchbanks, P. A., & Curtis, K. M. (2012) · Contraception · doi:10.1016/j.contraception.2012.08.011 · Cited by 50
Diagnosis, prevention, and treatment of scabies.
Shimose, L., & Munoz-Price, L. S. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0354-0 · Cited by 50
How reliable is self-testing for gonorrhea and chlamydia among men who have sex with men?
Sexton, M. E., BAKER, J. J., Nakagawa, K., Li, Y., Perkins, R., Slack, R. S., Baker, D. C., Jucha, B., Arora, S., & Plankey, M. W. (2013) · PubMed · Cited by 50
Partner Notification for HIV and Syphilis: Effects on Sexual Behaviors and Relationship Stability
KISSINGER, P. J., NICCOLAI, L. M., MAGNUS, M., FARLEY, T. A., MAHER, J. E., RICHARDSON-ALSTON, G., DORST, D., MYERS, L., & PETERMAN, T. A. (2003) · Sexually Transmitted Diseases · doi:10.1097/00007435-200301000-00015 · Cited by 50
Swedish, K. A., & Goldstone, S. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093393 · Cited by 50
Rape and subsequent seroconversion to HIV.
Murphy, S., Munday, P. E., & Jeffries, D. J. (1990) · BMJ · doi:10.1136/bmj.300.6717.118-c · Cited by 50
Baker, D. A., Ferris, D. G., Martens, M. G., et al. (2011) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2011/806105 · Cited by 50
Prenatal use of metronidazole and birth defects: No association
Alfaro, S. J. (1994) · Journal of Emergency Medicine · doi:10.1016/0736-4679(94)90377-8 · Cited by 50
Herpes Simplex Type-2 Meningitis: Presentation and Lack of Standardized Therapy
Landry, M. L., Greenwold, J., & Vikram, H. R. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.02.017 · Cited by 49
HIV-related sexual risk among transgender men who are gay, bisexual, or have sex with men.
Scheim, A. I., Bauer, G. R., & Travers, R. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001222 · Cited by 49
Chew Ng, R. A., Samuel, M. C., Lo, T., Bernstein, K. T., Aynalem, G., Klausner, J. D., & Bolan, G. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.300808 · Cited by 49
Self-citationWong, E. H., Klausner, J. D., Caguin-Grygiel, G., Madayag, C., Barber, K. O., Qiu, J. S., Liska, S., & Pandori, M. W. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318205491a · Cited by 49
Rape and subsequent seroconversion to HIV.
Murphy, S., Kitchen, V., Harris, J. R., & Forster, S. M. (1989) · BMJ · doi:10.1136/bmj.299.6701.718 · Cited by 49
A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy.
Zhou, P., Gu, Z., Xu, J., Wang, X., & Liao, K. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000170443.70739.cd · Cited by 49
A Trich-y Question: Should Trichomonas vaginalis Infection be Reportable?
Hoots, B., Peterman, T. A., Torrone, E., Weinstock, H., Meites, E., & BOLAN, G. A. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31827c08c3 · Cited by 49
Self-citationWatts, T., Stockman, L., Martin, J., Guilfoyle, S., & Vergeront, J. M. (2017) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6642a3 · Cited by 49
Fogel, C. I., Crandell, J., Neevel, A. M., Parker, S., Carry, M., White, B. L., Fasula, A. M., Herbst, J. H., & Gelaude, D. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.302105 · Cited by 49
Resistant Trichomoniasis: Successful Treatment With Combination Therapy
Nyirjesy, P., Gilbert, J., & Mulcahy, L. J. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31822037e4 · Cited by 49
Prevalence and predictors of sexually transmitted infection among newly incarcerated females.
Willers, D. M., Peipert, J. F., Allsworth, J. E., Stein, M. D., Rose, J. S., & Clarke, J. G. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318154bdb2 · Cited by 49
Sweeney, E. L., Trembizki, E., Bletchly, C., Bradshaw, C. S., Menon, A., Francis, F., Langton‐Lockton, J., Nimmo, G. R., & Whiley, D. M. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01555-18 · Cited by 49
Mycoplasma genitalium Infection in Women Attending a Sexually Transmitted Infection Clinic
Mobley, V., Hobbs, M. M., Lau, K. M., et al. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318255de03 · Cited by 49
Barbosa, C., Fraser, H., Hoerger, T. J., Leib, A., Havens, J. R., Young, A., Kral, A., Page, K., Evans, J., Zibbell, J., et al. (2019) · Addiction · doi:10.1111/add.14731 · Cited by 48
Hollman, D., Coupey, S. M., Fox, A. S., & Herold, B. C. (2010) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.03.004 · Cited by 48
Miller, M., Liao, Y., Wagner, M. E., & Korves, C. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31816b1fb8 · Cited by 48
Perkins, N., Nisbet, M., & Thomas, M. (2011) · Sexually Transmitted Infections · doi:10.1136/sti.2010.047431 · Cited by 48
Pellowski, J. A., Mathews, C., Kalichman, M. O., Dewing, S., Lurie, M. N., & Kalichman, S. C. (2016) · Journal of Health Communication · doi:10.1080/10810730.2015.1128020 · Cited by 48
Daskalopoulou, M., Rodger, A. J., Phillips, A. N., Sherr, L., Elford, J., McDonnell, J., Edwards, S., Perry, N., Wilkins, E., Collins, S., et al. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-053029 · Cited by 48
Novel interventions to reduce re-infection in women with chlamydia: a randomized controlled trial.
Cameron, S. T., Glasier, A., Scott, G., Young, H., Melvin, L., Johnstone, A., & Elton, R. (2009) · Human Reproduction · doi:10.1093/humrep/den475 · Cited by 48
Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors.
Loutfy, M. R., Macdonald, S., Myhr, T., Husson, H., Du Mont, J., Balla, S., Antoniou, T., & Rachlis, A. (2008) · Antiviral Therapy · doi:10.1177/135965350801300109 · Cited by 48
Extragenital Gonorrhea and Chlamydia Among Men and Women According to Type of Sexual Exposure
Bamberger, D. M., Graham, G. G., Dennis, L., & Gerkovich, M. M. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000967 · Cited by 48
High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM
Hoffmann, C., Sahly, H., Jessen, A., Ingiliz, P., Stellbrink, H., Neifer, S., Schewe, K., Dupke, S., Baumgarten, A., Kuschel, A., et al. (2013) · Infection · doi:10.1007/s15010-013-0501-4 · Cited by 48
Seronegative secondary syphilis in 2 patients coinfected with human immunodeficiency virus.
Kingston, A. A. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.4.431 · Cited by 48
Schlecht, H. P., Fugelso, D., Murphy, R., Wagner, K., Doweiko, J. P., Proper, J., Dezube, B. J., & Panther, L. (2010) · Clinical Infectious Diseases · doi:10.1086/653426 · Cited by 48
Tang, Y., Cleavinger, P. J., Li, H., Mitchell, P. S., Smith, T. F. A., & Persing, D. H. (2000) · Clinical Infectious Diseases · doi:10.1086/313616 · Cited by 48
Multinational experience with hypersensitivity drug reactions in Latin America.
Jares, E. J., Sánchez-Borges, M., Cardona-Villa, R., Ensina, L. F., Arias-Cruz, A., Gómez, M., Barayazarra, S., Bernstein, J. A., Serrano, C. D., Cuello, M. N., et al. (2014) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2014.06.019 · Cited by 48
Genital Warts and Vulvar Intraepithelial Neoplasia
Massad, L. S., Xie, X., Darragh, T. M., MINKOFF, H. L., Levine, A. M., Watts, D. H., Wright, R. L., DʼSouza, G., Colie, C. F., & Strickler, H. D. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31821a0f4d · Cited by 48
Adab, P., Marshall, T., Rouse, A., Randhawa, B., Sangha, H., & Bhangoo, N. (2003) · Journal of Epidemiology and Community Health · doi:10.1136/jech.57.8.589 · Cited by 48
Identification of macrolide‐resistant Mycoplasma genitalium using real‐time PCR
Wold, C., Sorthe, J., Hartgill, U., Olsen, A. O., Moghaddam, A., & Reinton, N. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12963 · Cited by 48
ACOG Committee Opinion No. 752: Prenatal and Perinatal Human Immunodeficiency Virus Testing
(2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002825 · Cited by 48
Evaluation of four commercial transport media for the survival of Neisseria Gonorrhoeae
Arbique, J. C., Forward, K. R., & LeBlanc, J. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00134-0 · Cited by 47
Confusion About Pap Smears: Lack of Knowledge Among High-Risk Women
Daley, E. M., Perrin, K. M., Vamos, C. A., Hernandez, N., Anstey, E. H., Baker, E. A., Kolar, S., & Ebbert, J. (2012) · Journal of Women s Health · doi:10.1089/jwh.2012.3667 · Cited by 47
Heiman, K. E., Karlsson, M., Grass, J. E., Howie, R. L., Kirkcaldy, R. D., Mahon, B. E., Brooks, J. T., & Bowen, A. B. (2014) · PubMed Central · Cited by 47
Schwebke, J. R., Marrazzo, J., Beelen, A. P., & Sobel, J. D. (2015) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000300 · Cited by 47
How safe is doxycycline for young children or for pregnant or breastfeeding women?
Wormser, G. P., Wormser, R. P., Strle, F., et al. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.09.015 · Cited by 47
Drake, C. A., Barenfanger, J. E., Lawhorn, J., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.3.1301-1303.2005 · Cited by 46
Susceptibility to hepatitis A virus infection in the United States, 2007–2016.
Yin, S., Barker, L., Ly, K. N., Kilmer, G., Foster, M. A., Drobeniuc, J., & Jiles, R. B. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa298 · Cited by 46
Chou, R., Selph, S., Dana, T., Bougatsos, C., Zakher, B., Blazina, I., & Korthuis, P. T. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-10-201211200-00007 · Cited by 46
Likely female-to-female sexual transmission of HIV--Texas, 2012.
(2014) · PubMed Central · Cited by 46
Dunne, E. F., Friedman, A., Datta, S., Markowitz, L. E., & Workowski, K. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir703 · Cited by 46
Self-citationPoncin, T., Mérimèche, M., Braille, A., Mainardis, M., Bébéar, C., Jacquier, H., & Berçot, B. (2019) · Eurosurveillance · doi:10.2807/1560-7917.es.2019.24.36.1900528 · Cited by 46
Shigella sonnei Outbreak Among Men Who Have Sex With Men--San Francisco, California, 2000-2001
(2002) · JAMA · doi:10.1001/jama.287.1.37 · Cited by 46
Mmeje, O., Chow, J. M., Davidson, L., Shieh, J., Schapiro, J. M., & Park, I. U. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ445 · Cited by 46
Self-citationDonovanosis in Australia: going, going...
Bowden, F. J. (2005) · Sexually Transmitted Infections · doi:10.1136/sti.2004.013227 · Cited by 45
Jin, F., Prestage, G. P., Templeton, D. J., Poynten, I. M., Donovan, B., Zablotska, I., Kippax, S. C., Mindel, A., & Grulich, A. E. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182401a2f · Cited by 45
Coexisting High-grade Vulvar Intraepithelial Neoplasia (VIN) and Condyloma Acuminatum
Maniar, K. P., Ronnett, B. M., Vang, R., et al. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318263cda6 · Cited by 45
Fan, H., Li, L., Wijlaars, L. P. M. M., & Gilbert, R. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212212 · Cited by 45
Panfilis, G. D., Melzani, G., MORI, G., et al. (2002) · Sexually Transmitted Diseases · doi:10.1097/00007435-200203000-00001 · Cited by 45
Harrison, C. M., Britt, H. C., Garland, S. M., Conway, L., Stein, A., Pirotta, M. V., & Fairley, C. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105967 · Cited by 45
Meites, E., Llata, E., Braxton, J. R., Schwebke, J. R., Bernstein, K. T., Pathela, P., Asbel, L. E., Kerani, R. P., Mettenbrink, C. J., & Weinstock, H. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000038 · Cited by 45
Lusk, M. J., Koneçny, P., Naing, Z., et al. (2010) · Sexually Transmitted Infections · doi:10.1136/sti.2010.045138 · Cited by 45
Geisler, W. M., Yu, S.-Y., & Hook, E. W. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000175390.45315.a1 · Cited by 45
The performance of anal cytology as a screening test for anal HSILs in homosexual men.
Jin, F., Grulich, A. E., Poynten, I. M., Hillman, R. J., Templeton, D. J., Law, C. L. H., Farnsworth, A., Garland, S. M., Fairley, C. K., Roberts, J. M., et al. (2016) · Cancer Cytopathology · doi:10.1002/cncy.21702 · Cited by 45
Rivard, K. R., Dumkow, L. E., Draper, H. M., et al. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.10.019 · Cited by 45
Boudová, S., Mark, K., & El‐Kamary, S. S. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy043 · Cited by 45
WHITTINGTON, W. L. H., CELUM, C. L., CENT, A., & ASHLEY, R. L. (2001) · Sex Transm Dis · doi:10.1097/00007435-200102000-00007 · Cited by 45
(1990) · PubMed · Cited by 45
Freeman, A. H., Katz, K. A., Pandori, M. W., Rauch, L. M., Kohn, R. P., Liska, S., Bernstein, K. T., & Klausner, J. D. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181bcd3fc · Cited by 44
Leeyaphan, C., Surawan, T. M., Chirachanakul, P., et al. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.02.002 · Cited by 44
Biswas, H. H., Chew Ng, R. A., Murray, E. L., Chow, J. M., Stoltey, J. E., Watt, J. P., & Bauer, H. M. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000782 · Cited by 44
Impact of HPV vaccination on anogenital warts and respiratory papillomatosis
Wangu, Z., & Hsu, K. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1172754 · Cited by 44
Per-partner condom effectiveness against HIV for men who have sex with men.
Johnson, W. D., O’Leary, A., & Flores, S. A. (2018) · AIDS · doi:10.1097/qad.0000000000001832 · Cited by 44
Connolly, K. L., Eakin, A. E., Gomez, C., Osborn, B. L., Unemo, M., & Jerse, A. E. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01644-18 · Cited by 43
Chan, P. A., Towey, C., Poceta, J., Rose, J., Bertrand, T., Kantor, R., Harvey, J., Santamaria, E. K., Alexander-Scott, N., & Nunn, A. (2016) · Public Health Reports · doi:10.1177/003335491613100210 · Cited by 43
Self-citationShedding of hepatitis C virus into the rectum of HIV-infected men who have sex with men.
Foster, A. L., Gaisa, M. M., Hijdra, R. M., Turner, S. S., Morey, T. J., Jacobson, K. B., & Fierer, D. S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw740 · Cited by 43
Evaluation of the endocervical Cytobrush and Cervex-Brush in pregnant women.
Paraiso, M. F. R., Brady, K., Helmchen, R., & Roat, T. W. (1994) · PubMed · Cited by 43
Improving Retention in HIV Care Through New York's Expanded Partner Services Data-to-Care Pilot
Tesoriero, J. M., Johnson, B. L., Hart-Malloy, R., et al. (2016) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000000483 · Cited by 43
Antimicrobial Desensitization: A Review of Published Protocols
Chastain, D. B., Hutzley, V. J., Parekh, J., & Alegro, J. V. G. (2019) · Pharmacy · doi:10.3390/pharmacy7030112 · Cited by 43
Muzny, C. A., Lensing, S. Y., Aaron, K. J., & Schwebke, J. R. (2019) · Sexually Transmitted Infections · doi:10.1136/sextrans-2018-053824 · Cited by 43
Self-citationAshshi, A. M., Batwa, S. A., Kutbi, S. Y., Malibary, F. A., Batwa, M., & Refaat, B. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1313-1 · Cited by 43
McIver, R., Jalocon, D., McNulty, A. M., Jeoffreys, N. J., Chen, S. C.-A., Power, M., & Couldwell, D. L. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001009 · Cited by 43
Lampkin, D., Crawley, A., Lopez, T. P., Mejia, C. M., Yuen, W., & Levy, V. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000930 · Cited by 42
Muzny, C., Barnes, A., & Mena, L. (2012) · Sexual Health · doi:10.1071/sh11114 · Cited by 42
Self-citationHepatitis C Virus universal screening versus risk based selective screening during pregnancy
Waruingi, W., Mhanna, M. J., Kumar, D., et al. (2016) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-15915024 · Cited by 42
Turner, K. R., Wong, E., Kent, C. K., & Klausner, J. D. (2002) · Sexually Transmitted Diseases · doi:10.1097/00007435-200207000-00011 · Cited by 42
Ong, J. J., Aung, E. T., Read, T. R. H., Fairley, C. K., Garland, S. M., Murray, G. L., Chen, M. Y., Chow, E. P. F., & Bradshaw, C. S. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000793 · Cited by 42
Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women
Páez-Canro, C., Alzate, J. P., González, L. M., Rubio-Romero, J. A., Lethaby, A., & Gaitán, H. G. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010871.pub2 · Cited by 42
Simms, I., Gilbart, V. L., Byrne, L., Jenkins, C., Adak, G. K., Hughes, G., & Crook, P. D. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.43.20946 · Cited by 42
Brinkley‐Rubinstein, L., Dauria, E., Tolou‐Shams, M., Christopoulos, K., Chan, P. A., Beckwith, C. G., Parker, S., & Meyer, J. P. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0389-9 · Cited by 41
Self-citationRate and Predictors of Repeat Chlamydia trachomatis Infection Among Men
Dunne, E. F., Chapin, J. B., RIETMEIJER, C. A. M., et al. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31817247b2 · Cited by 41
Bernstein, K. T., Stephens, S. C., Strona, F. V., Kohn, R. P., & Philip, S. S. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31827763ea · Cited by 41
Lusk, M. J., Garden, F. L., Rawlinson, W. D., et al. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052332 · Cited by 41
Research works printed but not linked: 13
- Golden MR, Kerani RP, Stenger M, Effect of expedited partner therapy (EPT) on chlamydial prevalence: the Washington State Community-Level Trial. Presented at the STD Prevention Conference, Minneapolis, MN; March 12–15, 2012.
- Lin JS, Eder M, Bean S. Screening for syphilis infection in pregnant women: a reaffirmation evidence update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 167. AHRQ Publication No. 18-05238-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2018. 30234936
- Benton S, Smith J, Wang F, Heitgerd J, Belcher L, Patel H. HIV testing, diagnosis, and linkage to care among persons tested in select CDC-funded health care and non-health care settings, 2012–2017. Presented at the National HIV Prevention Conference, Atlanta, GA: March 18–21, 2019.
- Briggs GC. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 11th ed. Philadelphia, PA: Wolters Kluwer; 2017.
- Blanco JL, Fuertes I, Bosch J, Effective treatment of lymphogranuloma venereum (LGV) with 1g azithormycin administered weekly for 3 weeks in HIV-infected population. Presented at the Conference on Retroviruses and Opportunist Infections, Seattle, WA; February 23–26, 2015.
- Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 · DOI · Paper page
- Ahmed KA, Fox SJ, Frigas E, Park MA. Clinical outcome in the use of cephalosporins in pediatric patients with a history of penicillin allergy. Int Arch Allergy Immunol 2012; 158: 405– 10. 10.1159/000333553 22487723 · DOI · Paper page
- Park IU, Chow JM, Bolan G, Stanley M, Shieh J, Schapiro JM. Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management. J Infect Dis 2011; 204: 1297– 304. 10.1093/infdis/jir524 21930610 · DOI · Paper page
- Muzny CA, Blackburn RJ, Sinsky RJ, Austin EL, Schwebke JR. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic. Clin Infect Dis 2014; 59: 834– 41. 10.1093/cid/ciu446 24928292 · DOI · Paper page
- Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis 2001; 33: 1341– 6. 10.1086/323034 11565074 · DOI · Paper page
- Perkins RB, Guido RS, Castle PE,; 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2020; 24: 102– 31. 10.1097/LGT.0000000000000525 32243307 PMC7147428 · DOI · Paper page
- Al Jaff DAA, Amin MHM. Comparison of the effectiveness of sulphur ointment, permethrin and oral ivermectin in treatment of scabies. Res J Pharm Biol Chem Sci 2018; 9: 670– 6.
- Chiu S, Argaez C. Ivermectin for parasitic skin infections of scabies: a review of comparative clinical effectiveness, cost-effectiveness, and guidelines. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; 2019. https://www.ncbi.nlm.nih.gov/books/NBK545083/ 31424718
Cited by
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2100644 · Cited by 2,698
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections
Luetkemeyer, A. F., Donnell, D., Dombrowski, J. C., Cohen, S., Grabow, C., Brown, C. E., Malinski, C., Perkins, R., Nasser, M., Lopez, C., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2211934 · Cited by 468
Towards a deeper understanding of the vaginal microbiota
France, M., Alizadeh, M., Brown, S., Ma, B., & Ravel, J. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01083-2 · Cited by 382
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Diagnosis and Treatment of Sexually Transmitted Infections: A Review
Tuddenham, S., Hamill, M. M., & Ghanem, K. G. (2022) · JAMA · doi:10.1001/jama.2021.23487 · Cited by 302
Metadata
- Authors
- Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A.
- Affiliations
- Emory University (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- Brown University (US)
- University of Washington (US)
- University of Alabama at Birmingham (US)
- Johns Hopkins University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Workowski, Kimberly A.
- ORCID
- Venue
- MMWR. Recommendations and Reports
- Published
- 2021-07-23
- Volume
- 70
- Issue
- 4
- Pages
- 1-187
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- PMC
- PMC8344968
- OpenAlex
- W3185444663
- Semantic Scholar
- eb300ecb7d38078ce65557d8188da1edbd3174fc
- Cited by
- 3,018
- References
- 1,505
- Citations by year
- 2026: 740 · 2025: 655 · 2024: 606 · 2023: 558 · 2022: 385 · 2021: 64
- FWCI
- 256.76
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- public-domain
- Locations
- MMWR Recommendations and Reports (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R25MH083620)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- sexually transmitted infections, STI treatment, gonorrhea, Chlamydia trachomatis, Trichomonas vaginalis, pelvic inflammatory disease, bacterial vaginosis, Mycoplasma genitalium, HPV vaccine, HCV screening, HIV prevention
- MeSH terms
- Centers for Disease Control and Prevention, U.S., Humans, Sexually Transmitted Diseases, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
